- Global Pharma News & Resources

Global Bioprocess Validation Market is Expected to Grow USD 551 Million by 2027

A new research report published by Fior Markets with the title Bioprocess Validation Market By Type (Integrity Testing, Microbiology Testing and Extractables and Leachable), Process Component (Bioreactors, Filter Elements), End Users (Biotechnology, Pharmaceutical Companies and CDMO) Regions And Global Forecast 2020-2027.

The global bioprocess validation market is expected to grow from USD 180 million in 2019 to USD 551 million by 2027, at a CAGR of 15.01% during the forecast period 2020-2027. Asia-Pacific region is expected to exhibit the largest market share. the increasing number of biopharmaceutical manufacturing capabilities in Asian countries, increasing demand for outsourcing bioprocess validation market, improving life science research and growth specific by pharmaceutical and biotechnology companies is expected to drive market growth in APAC. North America has the most of the key players which carries the market.


SGS S.A., Eurofins Scientific MEISSNER Filtration Products, INC., Thermo Fisher Scientific, Sartorius AG, Pall Corporation, Cobetter Filtration Equipments Co., Ltd., Toxikon Corporation, DOC S.R.L. and Merck KGaA are the key plauers of the global bioprocess validation market. These companies are mainly concentrated on the advancement of new technologies & devices; expand from their territories to grab the vital share of the global market.

The biggest pharma merger and acquisition deals of 2019: Initially announced in January 19, the deal got around 11 months unto Celgene became a fully controlled branch of BMS. The deal has increased the company‚Äôs pipelines in oncology, immunology, cardiovascular disease & haematology

The extractable/leachable testing services segment is expected to dominate the bioprocess validation market. The substantial share of this segment can be associated to the presence of regulatory orders and guidelines concerning the measurement of extractable and leachable. Growing outsourcing of testing services by biopharmaceutical manufacturers; the developing requirement for product safety, identity, purity, and quality; and the rising risk of product contamination. Based on end-users the market is segmented into biotechnology, pharmaceuticals & CDMO. The pharmaceutical companies are the major user of the bioprocess validation. The process component segment includes bioreactor and filter elements. Among the process component segment the bioreactor has the most significant market share of the market.


Customization of the Report:
The report can be customized as per client requirements. For further queries, you can contact us on or +1-201-465-4211. Our executives will be pleased to understand your requirements and offer you the best-suited reports.

Contact Us
Mark Stone
Phone: +1-201-465-4211

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 04-Jul-2020